aztreonam has been researched along with Microbial Superinvasion in 2 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aztreonam and cefotaxime were compared in 44 cirrhotic patients who had 52 episodes of gram-negative spontaneous peritonitis." | 9.07 | Aztreonam vs. cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patients. ( Alonso, T; Ariza, J; Esteve, M; Fernández Bañeres, F; Gudiol, F; Liñares, J; Xiol, X, 1991) |
| "In a prospective randomized, open study we evaluated aztreonam (AZ) for treatment of neonatal bacterial infections." | 9.06 | Evaluation of aztreonam and ampicillin vs. amikacin and ampicillin for treatment of neonatal bacterial infections. ( Castro, E; McCracken, GH; Odio, CM; Salas, JL; Umaña, MA, 1990) |
| "Aztreonam and cefotaxime were compared in 44 cirrhotic patients who had 52 episodes of gram-negative spontaneous peritonitis." | 5.07 | Aztreonam vs. cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patients. ( Alonso, T; Ariza, J; Esteve, M; Fernández Bañeres, F; Gudiol, F; Liñares, J; Xiol, X, 1991) |
| "In a prospective randomized, open study we evaluated aztreonam (AZ) for treatment of neonatal bacterial infections." | 5.06 | Evaluation of aztreonam and ampicillin vs. amikacin and ampicillin for treatment of neonatal bacterial infections. ( Castro, E; McCracken, GH; Odio, CM; Salas, JL; Umaña, MA, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ariza, J | 1 |
| Xiol, X | 1 |
| Esteve, M | 1 |
| Fernández Bañeres, F | 1 |
| Liñares, J | 1 |
| Alonso, T | 1 |
| Gudiol, F | 1 |
| Umaña, MA | 1 |
| Odio, CM | 1 |
| Castro, E | 1 |
| Salas, JL | 1 |
| McCracken, GH | 1 |
2 trials available for aztreonam and Microbial Superinvasion
| Article | Year |
|---|---|
Aztreonam vs. cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patients.
Topics: Adult; Aged; Ascitic Fluid; Aztreonam; Bacterial Infections; Cefotaxime; Female; Gram-Negative Bacte | 1991 |
Evaluation of aztreonam and ampicillin vs. amikacin and ampicillin for treatment of neonatal bacterial infections.
Topics: Amikacin; Ampicillin; Aztreonam; Bacterial Infections; Drug Evaluation; Drug Therapy, Combination; F | 1990 |